GlassScriptPhysician profile
Todd Michael Gerkin
NPI 1013991744
$1,022.89
in general payments reported to CMS, 2019-2025
24 companies · $18.54 in 2025
The $18.54 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $284 · 2020: $87.27 · 2021: $78.90 · 2022: $234 · 2023: $226 · 2024: $93.70 · 2025: $18.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $338.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endomagnetics LTD | $144.68 | 2023 | Magseed, Magtrace |
| Medtronic, INC. | $127.22 | 2022-2024 | Emprint, Ligasure |
| Ethicon US, LLC | $112.34 | 2019-2022 | |
| Innocoll Pharmaceuticals Limited | $55.98 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $52.06 | 2021 | |
| Wound Management Technologies, INC | $46.15 | 2019 | |
| Smith+Nephew, INC. | $44.40 | 2020-2022 | |
| Tetraphase Pharmaceuticals, INC. | $44.08 | 2019 | |
| Heron Therapeutics, INC. | $43.13 | 2024 | Zynrelef |
| Merck Sharp & Dohme LLC | $42.71 | 2020-2022 | |
| Kerecis Limited | $35.84 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Organogenesis INC. | $30.90 | 2024 | Puraply Am |
| Zimmer Biomet Holdings, INC. | $30.82 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $26.12 | 2019 | |
| Atricure, INC. | $25.29 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rti Surgical, INC | $24.85 | 2023 | |
| Bioptics, INC. | $19.10 | 2019 | |
| Csl Behring | $18.55 | 2019 | |
| Tela Bio, INC. | $18.54 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Davol INC. | $18.50 | 2022 | |
| Abbvie INC. | $17.40 | 2020 | |
| Checkpoint Surgical, INC | $16.31 | 2019 | |
| Cardinal Health 414 LLC | $14.83 | 2019 | |
| Shire North American Group INC | $13.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Gerkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.